BESTSMALLCAPSTOCKS2024
Discover investment opportunities in BESTSMALLCAPSTOCKS2024 using our Smart AI Filter.
AI is processing your request...
AI is analyzing your request
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in BESTSMALLCAPSTOCKS2024 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in BESTSMALLCAPSTOCKS2024 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in BESTSMALLCAPSTOCKS2024 using our Smart AI Filter.
7 stocks found for "BESTSMALLCAPSTOCKS2024"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
---|---|---|---|---|---|---|
1.18 Risk measure | ±85.7% Price volatility | -17.1 Valuation | 0.00% Annual yield | |||
1.56 Risk measure | ±52.2% Price volatility | 46.5 Valuation | 0.00% Annual yield | |||
0.66 Risk measure | ±47.0% Price volatility | 15.3 Valuation | 0.00% Annual yield | |||
1.35 Risk measure | ±93.0% Price volatility | 2.3 Valuation | 0.00% Annual yield | |||
0.37 Risk measure | ±34.2% Price volatility | -9.2 Valuation | 0.00% Annual yield | |||
1.21 Risk measure | ±61.6% Price volatility | -8.4 Valuation | 0.00% Annual yield | |||
1.79 Risk measure | ±77.1% Price volatility | -6.5 Valuation | 0.00% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: What makes EXPO a compelling investment within the small-cap sector?
A: EXPO, or Exponent Inc., operates in the consulting services industry, which is crucial for technical and scientific analyses. Its diverse client base spanning various industries may offer a competitive edge. Historical stability and consistent revenue streams can appeal to investors seeking defensiveness in small-cap investments.
Q: Does TMDX offer potential for growth-minded small-cap investors?
A: TMDX, or TransMedics Group, operates in the medical device field, focusing on organ transplant technologies. Given the growing demand for innovative healthcare solutions, TMDX may attract investors looking for growth opportunities fueled by advancements in medical technology.
Q: How does SWAV perform in times of economic uncertainty?
A: SWAV, or ShockWave Medical Inc., engages in manufacturing medical devices for cardiovascular disease treatment. Medical device companies like SWAV often experience stable demand, even during economic downturns, due to the essential nature of healthcare services.
Q: Are ARLO's technology products influencing their market position?
A: ARLO specializes in smart home security products. The increasing importance of home security solutions in an interconnected world may strengthen ARLO's market position. However, competitive pressure in the tech industry can affect future performance.
Q: Is INMD attractive for investors seeking innovative healthcare stocks?
A: INMD, or InMode Ltd., provides minimally invasive cosmetic medical products. Its strong focus on innovation and expanding market for aesthetic treatments may offer an interesting opportunity for investors prioritizing innovation in healthcare.
Q: What economic cycle considerations are relevant for MEDP?
A: MEDP, or Medpace Holdings Inc., is a clinical contract research organization. Such companies often see steady demand as pharmaceutical research remains a priority across economic cycles, providing a possible buffer during downturns.